Jump to content

Faralimomab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tom.Reding (talk | contribs) at 19:13, 19 September 2019 (Category:CS1 errors: deprecated parameters: migrate 1/1 |dead-url= to |url-status=; minor cleanup; WP:GenFixes on). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Faralimomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetInterferon receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1]

References

  1. ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on 2011-06-04. Retrieved 2009-09-24.


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Faralimomab&oldid=916612887"